🇺🇸 FDA
Patent

US 11299515

Optimized peptides for targeting human nerves and their use in image guided surgery, diagnostics and therapeutic

granted A61KA61K38/1825A61K38/185

Quick answer

US patent 11299515 (Optimized peptides for targeting human nerves and their use in image guided surgery, diagnostics and therapeutic) held by The Regents of the University of California expires Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K38/1825, A61K38/185, A61K38/30, A61K41/0057